moclobemide has been researched along with Cholestasis, Intrahepatic in 2 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Cholestasis, Intrahepatic: Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Timmings, P | 1 |
| Lamont, D | 1 |
| Dollow, S | 1 |
2 other studies available for moclobemide and Cholestasis, Intrahepatic
| Article | Year |
|---|---|
Intrahepatic cholestasis associated with moclobemide leading to death.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Benzamides; Cholestasis, Intrahepatic; Fatal Outcome | 1996 |
Antidepressant-associated fatal intrahepatic cholestasis.
Topics: Animals; Antidepressive Agents; Benzamides; Cholestasis, Intrahepatic; Fluoxetine; Humans; Moclobemi | 1996 |